Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 271-240-3 | CAS number: 68526-92-1 A complex combination of hydrocarbons produced by the distillation of products from the hydrogenation of isotridecanal from the hydroformylation of dodecene. It consists predominantly of C10-12 olefins and paraffins and C13 alcohols and aldehydes and boils in the range of approximately 160°C to 253°C (320°F to 487°F).
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16NOV 2012- 10FEB2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study has been performed according to OECD and/or EC guidelines and according to GLP principles.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- Dodecene, hydroformylation products, low-boiling
- EC Number:
- 271-240-3
- EC Name:
- Dodecene, hydroformylation products, low-boiling
- Cas Number:
- 68526-92-1
- Molecular formula:
- The substance consists of 46 isomers of unsaturated and branched dodecene structures (see Test Report No. A170002983).
- IUPAC Name:
- Dodecene, hydroformylation products, low-boiling
- Details on test material:
- - Name of test material (as cited in study report): Oxooil LS13
- Substance type: organic
- Physical state: Clear colourless liquid
- Storage condition of test material: In refrigerator (2-8°C) in the dark under nitrogen
- Hygroscopic: Yes, stored in well-sealed container
- Volatile: Yes, vapour pressure, 500 Pa at 20°C
- Reactivity: Reactive to oxygen
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- lymphocytes: Cultured peripheral human lymphocytes
- Details on mammalian cell type (if applicable):
- - Type and identity of media:
Blood samples
Blood samples were collected by venapuncture using the Venoject multiple sample blood collecting system with a suitable size sterile vessel containing sodium heparin. Immediately after blood collection lymphocyte cultures were started.
- Culture medium
Culture medium consisted of RPMI 1640 medium, supplemented with 20% (v/v) heat-inactivated (56°C; 30 min) foetal calf serum, L-glutamine (2 mM), penicillin/streptomycin (50 U/mL and 50 µg/mL respectively) and 30 U/mL heparin.
- Lymphocyte cultures
Whole blood (0.4 mL) treated with heparin was added to 5 mL or 4.8 mL culture medium (in the absence and presence of S9-mix, respectively). Per culture 0.1 ml (9 mg/mL) phytohaemagglutinin was added.
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: not applicable, immediately after blood collection lymphocyte cultures were started.
- Periodically checked for karyotype stability: yes
- Periodically "cleansed" against high spontaneous background: not applicable, immediately after blood collection lymphocyte cultures were started.
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver S9-mix induced by a combination of phenobarbital and ß-naphthoflavone.
- Test concentrations with justification for top dose:
- Dose range finding test:
Without S9-mix, 24hr exposure; 24 hr fixation: 1, 3, 10, 33, 100, 333, 1000 µg/mL
Without S9-mix, 48 exposure; 24 hr fixation: 1, 3, 10, 33, 100, 333, 1000 µg/mL
First cytogenetic test:
Without S9-mix, 3 h exposure time, 24 h fixation time: 10, 33, 100 µg/mL
With S9-mix, 3 h exposure, 24 h fixation time: 10, 33, 100 µg/ mL
Second cytogenetic test:
Without S9-mix, 24 hr exposure; 24 hr fixation: 1, 3, 10, 20, 30, 50, 75 µg/mL
Without S9-mix, 48 hr exposure; 48 hr fixation: 1, 3, 10, 20, 30, 50, 75 µg mL
With S9-mix, 3 hr exposure; 48 hr fixation: 10, 30, 100 µg/mL
Cytogenetic test 2A:
Without S9-mix, 24 hr exposure; 24 hr fixation: 1, 10, 30, 35, 40, 45, 50, 75 µg/mL - Vehicle / solvent:
- - Solvent used: ethanol
Controlsopen allclose all
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Remarks:
- 0.5 and 0.75 µg/ml for 3 h exposure period, 0.2 and 0.3 µg/ml for 24 h exposure period and
- Positive control substance:
- mitomycin C
- Remarks:
- without S9
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Remarks:
- 10 µg/ml
- Positive control substance:
- cyclophosphamide
- Remarks:
- with S9
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Preincubation period: 48 hr
- Exposure duration: 3 hr (with and without S9-mix), 24 and 48 hr (without S9-mix)
- Fixation time (start of exposure up to fixation or harvest of cells): 24 and 48 hr
SPINDLE INHIBITOR (cytogenetic assays): colchicine
STAIN (for cytogenetic assays): Giemsa
NUMBER OF REPLICATIONS: duplicates in two independent experiments
NUMBER OF CELLS EVALUATED: 100 metaphase chromosome spreads per culture
In cytogenetic assay 1, in the presence of S9-mix, at a concentration of 33 µg/ml, 92 metaphase spreads were examined for chromosome aberrations in one of the duplicate cultures treated with test substance. Evaluation: One hundred metaphase spreads were examined in the duplicate culture. Clear negative results were obtained at all concentrations. Scoring 8 additional metaphases would have given limited additional information and would not have any effect on the outcome of the study.
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index of each culture was determined by counting the number of metaphases per 1000 cells
OTHER EXAMINATIONS:
- Determination of polyploidy: yes
- Determination of endoreplication: yes - Evaluation criteria:
- A test substance was considered positive (clastogenic) in the chromosome aberration test if:
a) It induced a dose-related statistically significant (Chi-square test, one-sided, p < 0.05) increase in the number of cells with chromosome aberrations.
b) A statistically significant and biologically relevant increase in the frequencies of the number of cells with chromosome aberrations was observed in the absence of a clear dose-response relationship.
A test substance was considered negative (not clastogenic) in the chromosome aberration test if none of the tested concentrations induced a statistically significant (Chi-square test, one-sided, p < 0.05) increase in the number of cells with chromosome aberrations. - Statistics:
- The incidence of aberrant cells (cells with one or more chromosome aberrations, gaps included or excluded) for each exposure group outside the laboratory historical control data range was compared to that of the solvent control using Chi-square statistics.
Results and discussion
Test results
- Species / strain:
- lymphocytes: Cultured peripheral human lymphocytes
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- tested up to and above precipitating concentrations
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 50 µg/ml and above in the absence of S9
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: Precipitation in the exposure medium was observed at dose levels of 50 µg/ml and above.
RANGE-FINDING/SCREENING STUDIES:
- Toxicity (inhibition of the mitotic index of 50% or greater ) was observed at dose levels of 100 µg/ml and above in the absence of S9 (24hr or 48 hr treatment) in the range-finding study. In the first cytogenetic assay, no cytotoxcity was seen with or without metabolic activation. In the second cytogenetic assay, toxicity was seen at 50 µg/ml and above in the absence of S9, 24hr or 48 hr treatment. No cytotoxicity was recorded with metabolic activation. In cytogenetic assay 2A, toxicity was seen at 75 µg/ml in the absence of S9, 24hr treatment.
COMPARISON WITH HISTORICAL CONTROL DATA:
- The number of cells with chromosome aberrations found in the solvent and positive control cultures was within the laboratory historical control data range. Positive control chemicals, mitomycin C and cyclophosphamide induced appropriate responses.
ADDITIONAL INFORMATION ON CYTOTOXICITY:
- Appropriate toxicity was reached at the dose levels selected for scoring.
Any other information on results incl. tables
In the absence of S9-mix (24 h exposure time) no appropriate dose levels could be selected for scoring of chromosome aberrations since at the concentration of 30 µg/ml not enough cytotoxicity was observed (7%), whereas the next higher concentration of 50 µg/ml was too toxic for scoring (71%).
Therefore, the experiment was repeated in cytogenetic assay 2A.
No effects of Oxooil LS13 on the number of polyploid cells and cells with endoreduplicated chromosomes were observed both in the absence and presence of S9-mix.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
A chromosome aberration study with Oxooil LS13 was performed according to OECD 473 guideline and GLP principles, in cultured peripheral human lymphocytes in two independent experiments. It is concluded that Oxooil does not disturb mitotic processes and cell cycle progression and does not induce numerical chromosome aberrations in human lymphocytes. - Executive summary:
A chromosome aberration study with Oxooil LS13 was performed according to OECD 473 guideline and GLP principles, in cultured peripheral human lymphocytes in two independent experiments. The test substance was tested up to and beyond precipitating concentrations. Both in the absence and presence of S9-mix, Oxooil LS13 did not induce a statistically significant or biologically relevant increase in the number of cells with chromosome aberrations. No effects of Oxooil LS13 on the number of polyploid cells and cells with endoreduplicated chromosomes were observed both in the absence and presence of S9-mix.
It can be concluded that Oxooil LS13 does not disturb mitotic processes and cell cycle progression and does not induce numerical chromosome aberrations under the experimental conditions described in this report.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.